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(blaPER-1 and blaVIM-2) had been detected separately among 
clinical isolates, underscores the possibility of the emergence 
of new threatening combinations of resistance determinants 
among nosocomial pathogens. In fact, the recruitment of 
similar resistance determinants within a single P. aerugi-
nosa strain can determine a resistance phenotype to virtu-
ally all the available antipseudomonal beta-lactams, an 
occurrence that can be particularly dramatic when, as in the 
present case, resistance to beta-lactams is associated with 
resistance against aminoglycosides and fluoroquinolones. In 
this case, only piperacillin (which appears to be a relatively 
poor substrate for both enzymes [3,5]) retained moderate 
activity in vitro and, administered at high dosage in combi-
nation with tazobactam, was apparently effective in vivo. 
Should a similar resistance phenotype disseminate, it might 
have strategic implications for the development of new beta-
lactamase inhibitors and for selection of beta-lactam com-
pounds to associate wth inhibitors.
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Jamestown Canyon Virus: Seroprevalence in 
Connecticut
To the Editor: Jamestown Canyon virus (JCV), a member of 
the California serogroup, has a wide geographic distribution 
throughout much of temperate North America. It causes 
mild febrile illness and, rarely, aseptic meningitis or primary 
encephalitis (1). JCV has been isolated from mosquitoes each 
year that surveys have been done in Connecticut, and 28 
positive pools from 10 mosquito species were found during 
2000 (T. Andreadis, pers. commun.). In contrast, only 14 pos-
itive mosquito pools were found to contain West Nile virus 
(WNV), which has recently been introduced into Connecticut 
(2). JCV has been isolated from Aedes mosquitoes in Con-
necticut, and serologic evidence suggests it is widespread in 
deer (3,4). No recent seroprevalence surveys have been done 
in Connecticut, nor have any human cases of infection or dis-
ease due to JCV been documented. 
We report the results of two seroprevalence surveys 
done with standard indirect fluorescent assays (IFA) to 
detect immunoglobulin G antibodies to JCV. One survey 
examined 1,086 sera collected in 1990 from blood donors. 
The second survey examined 1,016 sera submitted to the 
Connecticut State Public Health Laboratory in 1995.
The IFA used JCV-infected baby hamster kidney cells 
(BHK-21). Infected and uninfected cell suspensions were air 
dried and fixed onto Teflon-coated, 12-well slides. Prepared 
slides were stored at -70°C. Sera were tested at a minimum 
dilution of 1:16. After incubation and washing of the fluores-
cein-conjugated counterstain, slides were dried and exam-
ined by fluorescent microscope (American Optical, Buffalo, 
NY). The positive human control serum was designated as 
the 4+ baseline with which the test sera were compared. 
Selected sera were tested by a serum dilution plaque reduc-
tion neutralization test (PRNT) assay with JCV, La Crosse 
virus, and trivittatus virus.
Of the 1,086 sera collected from blood donors in 1990, 
164 (15%) were positive by IFA at a minimum dilution of 
1:16. Because IFA screening procedures are known to have 
poor specificity, a subset of 39 IFA-positive and 5 IFA-nega-
tive sera was tested by PRNT. None of the IFA-negative sera 
were positive, while 26 (67%) of the 39 IFA-positive sera 
were positive for JCV antibodies. Extrapolating the PRNT 
results to the 164 IFA-positive sera yields an overall positiv-
ity rate of 10.1%. 
The second serosurvey, performed on 1,016 sera col-
lected in 1995 from apparently healthy patients requesting 
immune status testing to viruses such as Varicella zoster or 
measles, had 57 IFA-positive specimens. Extrapolating addi-Letters
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tional PRNT results from 26 sera, of which 18 (69%) were 
positive, yields a 3.9% positivity rate. 
In addition to our study, with crude seroprevalence rates 
ranging from 3.9% to 10.1%, another recent study demon-
strated JCV antibodies in 2.9% to 13.3% of ill persons in 
Massachusetts (Tonry J et al., unpub. data). Although the 
screening results of our first serosurvey (10.1% positive) dif-
fered widely from those of the second serosurvey (3.9% posi-
tive), even the lower rate indicates substantial levels of 
human infection in Connecticut.
This report suggests that JCV infection is fairly fre-
quent in Connecticut and that illness may occur, as corrobo-
rated by data from neighboring Massachusetts (Tonry J et 
al., unpub. data) and unpublished laboratory findings from 
the Connecticut State Public Health Laboratory. The inter-
est in arboviral disease will continue unabated, spurred by 
the continued occurrence of WNV, and systematic testing for 
JCV infection may be timely, at least throughout the north-
eastern United States.
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A Newly Discovered Variant of a Hantavirus in 
Apodemus peninsulae, Far Eastern Russia
To the Editor: Hemorrhagic fever with renal syndrome 
(HFRS) is caused by Hantaan virus (HTNV) or Seoul virus 
(SEO) in Asia and Puumala virus (PUUV) or Dobrava virus 
(DOBV) in Europe (1). Each of these hantaviruses is predom-
inantly associated with a single rodent species as its primary 
natural reservoir: HTNV with the striped field mouse Apode-
mus agrarius, SEO with Rattus norvegicus, PUUV with the 
bank vole Clethrionomys glareolus, and DOBV with the yel-
low-necked mouse Apodemus flavicollis. An additional 
rodent reservoir of DOBV, A. agrarius, was reported recently 
(2). 
The first HFRS cases (then called “hemorrhagic neph-
roso-nephritis”) were clinically described in the Amur River 
basin during the 1920s by Russian scientists (3). Serologic 
studies suggest that numerous hantaviruses are present in 
humans and rodents in the far east of Asian Russia (4-5). 
Serologic evidence of hantavirus infection in A. agrarius, A. 
peninsulae (Korean field mouse), R. norvegicus, Cl. rufoca-
nus, Cl. rutilus, and Microtus fortis has been reported (5). 
Only Khabarovsk virus (KBR), isolated from M. fortis, has 
been characterized in detail, and no association with human 
disease was established (6). 
To genetically characterize hantaviruses in A. peninsu-
lae, we studied samples from rodents captured in July and 
August 1998 in the same region of the forest near Kha-
barovsk. Lung-tissue samples were screened by enzyme-
linked immunosorbent assay for HTNV/SEO/PUUV-related 
antigen. Samples from four hantavirus-positive rodents were 
tested by reverse transcription and nested polymerase chain 
reaction (PCR). Four M-segment PCR products (nt 2639-
3000) and two S-segment PCR products (nt 592-945) were 
produced and directly sequenced (GenBank accession num-
bers AF332569-AF332573). All sequences were closely 
related to each other, with nucleotide diversity between 
strains not exceeding 0.6% for M segments and 1.3% for S 
segments. Comparative analysis of the M segments showed 
that hantaviral nucleotide sequences from A. peninsulae 
were very similar to those we identified earlier in HFRS 
patients (diverging 3.1% to 6.6%), which we term the Amur 
genotype of HTNV (7). The S-segment sequences of the AMR 
genotype from human patients were not available for com-
parison. The nucleotide sequence (the M and S segments, 
respectively) of the hantavirus detected in A. peninsulae 
diverged substantially from those of other hantaviruses (15% 
and 19% for HTNV, 21% to 28% for SEO, 22% and 29% for 
DOBV, 38% and 39% for PUUV, and 36% and 37% for KBR). 
Neighbor-joining phylogenetic analysis based on partial 
sequences of the S segment indicated that the hantaviral 
sequences from A. peninsulae form a separate lineage on the 
phylogenetic tree, and together with HTNV virus strain 76-
118, which originates from A. agrarius, constitute a well-
supported group. A phylogenetic tree based on partial M seg-
ment sequences placed all hantavirus strains originating 
from A. peninsulae or from HFRS patients apart from all 
HTNV sequences recovered from A. agrarius (strain 76-118) 
and HFRS patients from Korea (strains HoJo, Lee). The tax-
onomic placement of this hantavirus (Amur genotype) as a 
distinct hantavirus or a distinct genetic lineage of HTNV 
remains to be determined. In addition, the finding of distinct 
DOBV genetic lineages in A. flavicollis and A. agrarius 
raises the same question of whether the two DOBV variants 
represent distinct hantaviruses (2). 
A. peninsulae is widely distributed throughout eastern 
Asia, from Altai and south Siberia to the Russian far east, 
northeastern and eastern parts of China, and Korea. A sur-
vey of hantavirus antigens in rodent populations in the far 
east of Russia demonstrated the presence of HTNV-like anti-
gen in 8% to 16% of A. peninsulae (5). Whether pathogenic 
AMR genotype of virus exists in A. peninsulae throughout 
far eastern Asia, from Russia to China and Korea, requires 
further study. Comparing hantaviral genome sequences 
available from GenBank shows that the M segment nucle-
otide sequence recovered from an HFRS patient from China 
(strain H8205, GenBank accession number AB030232) was 
very similar to the AMR genotype from A. peninsulae (94% to 